Drug intelligence / Profile preview

Baoxin Granules

Development stage
Unknown
Lead developer
China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica
Modality
Small Molecules
Administration
Oral
01

Overview

Baoxin Granules is a Traditional Chinese Medicine (TCM) formulation developed by the Institute of Chinese Materia Medica at the China Academy of Chinese Medical Sciences for the treatment of chronic heart failure (CHF). It is specifically designed to treat patients with the TCM syndrome of Qi deficiency and blood stasis. The granules are composed of several herbal extracts, including *Astragalus membranaceus* (Huangqi), *Salvia miltiorrhiza* (Danshen), *Panax ginseng* (Renshen), and *Descurainia sophia* (Tinglizi). The therapeutic mechanism involves improving myocardial energy metabolism, enhancing cardiac contractility, and inhibiting ventricular remodeling by modulating inflammatory cytokines and fibrotic pathways. Clinical studies in China have demonstrated that Baoxin Granules can improve the New York Heart Association (NYHA) functional class, increase the left ventricular ejection fraction (LVEF), and enhance the quality of life in patients with stable chronic heart failure.

Brand names
Baoxin Granules
Other names
Baoxin KeliBǎoxīn Kēlì
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))TGFB1 (Transforming growth factor Beta-1 proprotein)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Baoxin Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baoxin Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call